Autosomal recessive non-syndromic intellectual disability

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Mar 2026OJJAARA: New indication approved
FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Autosomal recessive non-syndromic intellectual disability.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Autosomal recessive non-syndromic intellectual disability.
Search all trials →
Search clinical trials for Autosomal recessive non-syndromic intellectual disability

Recent News & Research

1 article
BREAKINGFDA

FDA Approves OJJAARA

OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) received FDA approval.

Read ↗

Browse all Autosomal recessive non-syndromic intellectual disability news →

Specialist Network

No specialists currently listed for Autosomal recessive non-syndromic intellectual disability.

View all Autosomal recessive non-syndromic intellectual disability specialists →

Quick Actions